Deadline: 16-Sep-2026
The European Commission Advanced Health Technologies Grant 2026 supports research and innovation projects developing next-generation healthcare technologies, including wearable health systems, personalised medical imaging, biomedical research tools, AI-based monitoring solutions, and advanced laboratory technologies. The call provides a total budget of €20 million to strengthen Europe’s capabilities in health technology innovation.
Eligible legal entities from EU Member States, EEA countries, Associated Countries, OECD countries, and Mercosur countries can apply for project funding ranging from €1 million to €20 million under the Chips Joint Undertaking (Chips JU) framework.
What Is the Advanced Health Technologies Grant?
The European Commission Advanced Health Technologies Grant supports research and innovation activities aimed at developing advanced technologies that improve healthcare, medical research, diagnostics, and treatment development.
The initiative focuses on integrating semiconductor-based technologies with healthcare applications to create innovative solutions for:
- Disease prevention
- Early diagnosis
- Personalised medicine
- Patient monitoring
- Biomedical research
- Medical equipment development
The programme contributes to Europe’s goal of strengthening its healthcare technology ecosystem through advanced research and innovation.
Why Advanced Health Technologies Matter
Modern healthcare increasingly depends on advanced digital and biomedical technologies.
Innovative health technologies can improve:
- Early disease detection
- Treatment accuracy
- Patient monitoring
- Healthcare efficiency
- Medical research capabilities
- Personalised healthcare delivery
Advanced systems combining artificial intelligence, sensors, imaging, and biomedical research tools can help healthcare professionals make faster and more accurate decisions.
Objectives of the Grant Programme
The call aims to support the development of advanced health technologies that:
- Improve medical research capabilities
- Strengthen diagnostic methods
- Support personalised healthcare
- Enable real-time health monitoring
- Advance medical treatment development
- Improve healthcare outcomes
The programme encourages collaboration between technology developers, healthcare researchers, and scientific organisations.
Key Research Areas Supported
The funding call focuses on several advanced health technology areas.
1. Integrated Technologies for Health Monitoring
Projects may develop advanced systems for continuous health monitoring.
Supported innovations may include:
- Wearable health devices
- Integrated monitoring platforms
- Sensor-based health technologies
- Real-time patient tracking systems
These technologies can support early detection and personalised healthcare management.
2. Advanced Wearable Health Technologies
The programme supports research into wearable healthcare solutions that enable:
- Continuous health monitoring
- Remote patient observation
- Personalised health insights
- Real-time data collection
Examples may include:
- Smart health sensors
- Wearable medical devices
- Connected healthcare systems
3. AI-Driven Patient Monitoring Solutions
Artificial intelligence can improve healthcare decision-making through:
- Automated health analysis
- Predictive monitoring
- Risk identification
- Personalised recommendations
Projects may focus on AI systems that analyse patient data and support healthcare professionals.
4. Personalised Imaging Technologies
The call supports innovation in medical imaging systems designed for personalised healthcare.
Research areas may include:
- Advanced imaging technologies
- Improved diagnostic accuracy
- Patient-specific imaging approaches
- Faster medical analysis
These technologies aim to improve disease detection and treatment planning.
5. Advanced Laboratory and Scientific Solutions
Funding supports advanced research tools and laboratory technologies, including:
- Biomedical research instruments
- Scientific analysis systems
- Molecular-level investigation tools
- Advanced experimental technologies
These solutions help researchers better understand diseases and develop new treatments.
6. Molecular-Scale Disease Investigation
Projects may investigate diseases at molecular levels to support:
- Better understanding of disease mechanisms
- New treatment approaches
- Improved diagnostic methods
- Biomedical discoveries
7. Medical Treatment Development and Validation
The programme supports technologies that contribute to:
- Development of new treatments
- Testing and validation of medical techniques
- Improvement of medical equipment
- Clinical research support
Key Innovation Areas
The call addresses several technological challenges, including:
- AI integration in healthcare
- Real-time health monitoring
- Advanced biomedical sensing
- Personalised diagnostics
- Medical imaging improvements
- Scientific instrument development
- Healthcare technology validation
Available Funding
The European Commission has allocated:
- Total available budget: €20,000,000
- Minimum project funding: €1,000,000
- Maximum project funding: €20,000,000
The final grant amount depends on:
- Project scope
- Research objectives
- Innovation potential
- Consortium capacity
- Expected healthcare impact
Who Is Eligible to Apply?
Eligibility requirements are defined under:
Annex 1 to the Multiannual Work Programme 2023–2027 “HORIZON Europe conditions applicable to the Chips JU”.
Applicants must be legal entities established in eligible countries.
Eligible Countries
Participation is open to organisations established in:
- European Union Member States
- European Economic Area (EEA) countries
- Associated Countries
- OECD countries
- Mercosur countries
Eligible Organisation Types
Potential applicants may include:
- Universities
- Research institutions
- Healthcare technology companies
- Biomedical organisations
- Medical equipment developers
- Technology research centres
- Innovation organisations
Applicants should have relevant expertise in advanced health technologies.
Participation Requirements for Controlled Entities
Organisations established in eligible countries but controlled directly or indirectly by entities from non-eligible countries must provide approved guarantees.
These guarantees must confirm that participation:
- Does not harm EU strategic interests
- Does not compromise security
- Does not affect European technological autonomy
- Does not negatively impact EU assets
Restrictions on High-Risk Suppliers
Certain organisations are not eligible.
Entities that are:
- Assessed as high-risk suppliers of mobile network communication equipment
- Fully or partially owned or controlled by such suppliers
cannot submit guarantees and cannot participate in the call.
How to Apply for the Advanced Health Technologies Grant
Applicants should follow these steps:
Step 1: Review Eligibility Requirements
Applicants should confirm:
- Organisation eligibility
- Country eligibility
- Compliance with Chips JU rules
- Security requirements
Step 2: Develop a Research Proposal
The proposal should explain:
- The healthcare challenge being addressed
- The technology solution
- Research methodology
- Expected healthcare benefits
- Innovation potential
Step 3: Build a Strong Research Consortium
Projects may benefit from collaboration between:
- Healthcare researchers
- Technology developers
- Medical institutions
- Semiconductor experts
- Scientific organisations
Step 4: Demonstrate Impact
Applicants should explain how their project will contribute to:
- Better healthcare outcomes
- Improved diagnostics
- Medical innovation
- European health technology leadership
Step 5: Submit the Application
Applicants must submit proposals according to European Commission and Chips JU application procedures.
Tips for a Strong Application
Applicants should:
- Clearly explain healthcare benefits
- Demonstrate technical innovation
- Include strong research expertise
- Address real medical challenges
- Highlight AI and digital technology opportunities
- Explain scalability and future adoption potential
Common Mistakes to Avoid
Applicants should avoid:
- Proposing technologies without healthcare relevance
- Providing unclear innovation objectives
- Ignoring data and validation requirements
- Weakly describing expected impact
- Failing to meet eligibility rules
- Overlooking security requirements
Frequently Asked Questions (FAQ)
What is the purpose of the Advanced Health Technologies Grant?
The grant supports research and innovation projects developing advanced healthcare technologies for monitoring, imaging, biomedical research, diagnostics, and treatment development.
How much funding is available?
The programme provides €20 million in total funding, with individual projects eligible for between €1 million and €20 million.
What technologies are supported?
Supported technologies include wearable health systems, AI-based monitoring, personalised imaging, biomedical research tools, advanced laboratory solutions, and medical equipment validation technologies.
Who can apply?
Legal entities established in EU Member States, EEA countries, Associated Countries, OECD countries, and Mercosur countries can apply if they meet Chips JU requirements.
Can organisations controlled by non-eligible countries participate?
They may participate only if they provide approved guarantees confirming that their involvement does not negatively affect EU strategic interests, security, autonomy, or assets.
Are high-risk mobile network equipment suppliers eligible?
No. Entities identified as high-risk suppliers, or organisations controlled by them, cannot participate.
Why does Europe support advanced health technology research?
Advanced health technologies can improve diagnosis, treatment, healthcare efficiency, and Europe’s ability to develop innovative medical solutions.
Conclusion
The European Commission Advanced Health Technologies Grant 2026 provides a major opportunity to advance healthcare innovation through cutting-edge research and technology development.
By supporting wearable health systems, AI-powered monitoring, personalised imaging, biomedical research tools, and advanced medical technologies, the programme aims to improve healthcare outcomes and strengthen Europe’s position in global health innovation.
Researchers, technology organisations, and healthcare innovators can use this funding opportunity to develop solutions that transform medical research, diagnosis, and treatment for future generations.
For more information, visit European Commission.